Clinical trials
Phase 3 Angioedemas, Hereditary trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 5 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 3 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 6 |
| 2022 | 6 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
| Active, not recruiting | 5 |
| Recruiting | 4 |
| Enrolling by invitation | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shire | 20 |
| BioCryst Pharmaceuticals | 5 |
| CSL Behring | 5 |
| KalVista Pharmaceuticals, Ltd. | 4 |
| Pharvaris Netherlands B.V. | 4 |
| Ionis Pharmaceuticals, Inc. | 3 |
| Takeda | 3 |
| ADARx Pharmaceuticals, Inc. | 2 |
| Astria Therapeutics, Inc. | 2 |
| Pharming Technologies B.V. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Angioedemas, Hereditary | 53 |
| Angioedema | 6 |
| Hereditary Angioedema Types I and II | 2 |
| Genetic Diseases, Inborn | 1 |
| Hereditary Angioedema Type III | 1 |
| Inflammation | 1 |
| Multiple Organ Failure | 1 |
| Sepsis | 1 |
| Wounds and Injuries | 1 |
Trials
Showing 51 to 53 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.